Journal Home
Search for

Volume 93, Issue 3, Pages 539-544 (December 2009)


View previous. 30 of 52 View next.

Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer

Shreerang A. BhideabCorresponding Author Informationemail address, Sarah Gulliforda, Rehan Kazib, Iman El-Hariryb, Kate Newboldb, Kevin J. Harringtonab, Christopher M. Nuttingb

Received 23 May 2009; received in revised form 29 September 2009; accepted 30 September 2009. published online 02 November 2009.

Abstract 

Purpose

Aim of this study was to correlate dose to pharyngeal constrictors (PC) with subjective and observer-based assessments of swallowing in patients with head and neck cancer undergoing concomitant chemo-IMRT.

Materials and methods

Dose–volume histograms (DVHs) for superior constrictor (SC), middle constrictor (MC) and inferior constrictor (IC) were generated for 37 patients. Mean doses to SC, MC and IC were correlated to objective dysphagia grade (1year, RTOG scoring) and global, total physical (TP) and most relevant components of the physical section (P6, P8) of the MD Anderson dysphagia inventory (MDADI) which was evaluated post-treatment. Odds ratios of dysphagia (>grade 0), poor global (<3), TP (<32), P6 (<3) and P8 (<3) for patients with mean dose>60Gy to SC and IC were calculated.

Results

There was no significant correlation between mean dose to PC and any of the analysed MDADI parameters and observer-assessed dysphagia grade. Odds ratio of dysphagia (>grade 0), poor global (<3), TP (<32), P6 (<3) and P8 (<3) for patients with mean dose>60Gy to IC and SC were not significantly higher than those for patients receiving <60Gy.

Conclusion

This study did not find a statistically significant correlation between radiation dose to the PC and observer-assessed dysphagia grade or patient-reported MDADI questionnaire at 1year.

a The Institute of Cancer Research, London, UK

b The Royal Marsden NHS Foundation Trust Hospital, London, UK

Corresponding Author InformationCorresponding author. Address: Royal Marsden Hospital, Head and Neck Oncology Unit, Fulham Road, London SW3 6JJ, UK.

 This manuscript was presented as an abstract at the ESTRO 2008 meeting in Gothenburg.

PII: S0167-8140(09)00565-9

doi:10.1016/j.radonc.2009.09.017


View previous. 30 of 52 View next.